Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Primitive malignant progenitors defined as nonobese diabetic/severe combined immunodeficient (NOD/SCID) leukemia-initiating cells or NOD/SL-IC from patients with acute myeloid leukemia (AML) can be detected and quantitated in sublethally irradiated NOD/SCID mice. However, there is variability in the levels of bone marrow (BM) engraftment obtained after intravenous injection of cells from different AML samples. In the current study, AML cell engraftment in standard NOD/SCID mice was compared to that obtained with NOD/SCID mice transgenic for the human growth factor genes Steel factor (SF), interleukin-3 (IL-3) and granulocyte macrophage-colony-stimulating factor (GM-CSF) (N/S-S/GM/3) as well as beta 2 microglobulin-null NOD/SCID (N/S-beta 2m(-/-)) mice. Three of the eight AML samples that failed to engraft in standard NOD/SCID animals showed easily detectable and up to 70-fold increased in the number of leukemic cells in BM 8-12 weeks post-transplantation in each of the N/S-beta 2m(-/-) and N/S-S/GM/3 mouse strains. In two of the four AML samples studied at limiting dilution, the frequency of NOD/SL-IC detected was increased six- and seven-fold. Thus, in these novel mouse strains a broader spectrum of AML patient samples can be evaluated for their progenitor content and potentially studied for their response to innovative therapeutics in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AML leukemia initiating cells frequently have surface-phenotype features of lineage-commitment (CD34+38+, CLL-1+, CD71+, CD90−, c-Kit-)(42–52).”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [50]
Citations
Cites
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
BENNETT, J. M., CATOVSKY, D., DANIEL, M. T., FLANDRIN, G., GALTON, D. A. G., GRALNICK, H. R., & SULTAN, C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-620 · Cited by 2,926
Multiple defects in innate and adaptive immunologic function in NOD/LtSz- scid mice.
Shultz, L. D., Schweitzer, P. A., Christianson, S. W., Gott, B., Schweitzer, I. B., Tennent, B., McKenna, S., Mobraaten, L., Rajan, T. V., Greiner, D. L., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.180 · Cited by 1,223
Blair, A., Hogge, D. E., Ailles, L. E., Lansdorp, P. M., & Sutherland, H. J. (1997) · Blood · doi:10.1182/blood.v89.9.3104 · Cited by 335
Self-citationEnhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice
Christianson, S. W., Greiner, D. L., Hesselton, R. A., Leif, J. H., Wagar, E. J., Schweitzer, I. B., Rajan, T. V., Gott, B., Roopenian, D. C., & Shultz, L. D. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3578 · Cited by 237
Blair, A., Hogge, D. E., & Sutherland, H. J. (1998) · Blood · doi:10.1182/blood.v92.11.4325 · Cited by 236
Self-citationHogge, D., Lansdorp, P., Reid, D., Gerhard, B., & Eaves, C. (1996) · Blood · doi:10.1182/blood.v88.10.3765.bloodjournal88103765 · Cited by 207
Self-citationGlimm, H., Eisterer, W., Lee, K., Cashman, J., Holyoake, T. L., Nicolini, F., Shultz, L. D., von Kalle, C., & Eaves, C. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11519 · Cited by 201
Self-citationKollet, O., Peled, A., Byk, T., Ben-Hur, H., Greiner, D., Shultz, L., & Lapidot, T. (2000) · Blood · doi:10.1182/blood.v95.10.3102 · Cited by 183
Blair, A., & Sutherland, H. J. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00155-7 · Cited by 165
Ailles, L. E., Gerhard, B., Kawagoe, H., & Hogge, D. E. (1999) · Blood · doi:10.1182/blood.v94.5.1761 · Cited by 154
Self-citationCharacterization of a hierarchy in human acute myeloid leukemia progenitor cells
Sutherland, H., Blair, A., & Zapf, R. (1996) · Blood · doi:10.1182/blood.v87.11.4754.bloodjournal87114754 · Cited by 135
Feuring‐Buske, M., & Hogge, D. E. (2001) · Blood · doi:10.1182/blood.v97.12.3882 · Cited by 122
Self-citationBonnet, D. A., Bhatia, M., Wang, J., Kapp, U., & Dick, J. E. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701564 · Cited by 117
Feuring‐Buske, M., Frankel, A. E., Alexander, R. L., Gerhard, B., & Hogge, D. E. (2002) · PubMed · Cited by 113
Self-citationAilles, L. E., Gerhard, B., & Hogge, D. E. (1997) · Blood · doi:10.1182/blood.v90.7.2555 · Cited by 98
Self-citationRombouts, W., Martens, A., & Ploemacher, R. (2000) · Leukemia · doi:10.1038/sj.leu.2401777 · Cited by 83
Ailles, L., Gerhard, B., Kawagoe, H., et al. (1999) · Blood · doi:10.1182/blood.v94.5.1761.417k23_1761_1772 · Cited by 64
Self-citationHigh marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice
Cashman, J. D., & Eaves, C. J. (2000) · Blood · doi:10.1182/blood.v96.12.3979 · Cited by 56
Self-citationTerpstra, W. E., Leenen, P., van den Bos, C., Prins, A., Loenen, W. A. M., Verstegen, M. M. A., Wyngaardt, S. V., van Rooijen, N., Wognum, A., Wagemaker, G., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400694 · Cited by 32
Feuring‐Buske, M., Frankel, A. E., Gerhard, B., & Hogge, D. E. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00542-7 · Cited by 27
Self-citationPolyclonal normal hematopoietic progenitors in patients with acute myeloid leukemia
Guan, Y., Ralph, S. G., & Hogge, D. E. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00824-x · Cited by 11
Self-citationCytokine responsiveness of primitive progenitors in acute myelogenous leukemia.
Hogge, D. E., Ailles, L., & Gerhard, B. (1997) · PubMed · Cited by 5
Self-citation
Research works printed but not linked: 1
- Nicolini FE, Cashman JD, Humphries RK, Eaves CJ . Transplantation of human marrow in NOD/SCID mice genetically engineered to continuously produce human IL-3, GM-CSF and Steel Factor (SF) results in increased numbers of human progenitors in the circulation without compromising overall engraftment. Blood 2000; 96: 292a (Abstract).
Cited by
Tumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
The cancer stem cell: premises, promises and challenges
Clevers, H. (2011) · Nature Medicine · doi:10.1038/nm.2304 · Cited by 1,923
Efficient tumour formation by single human melanoma cells
Quintana, E., Shackleton, M., Sabel, M. S., Fullen, D. R., Johnson, T. M., & Morrison, S. J. (2008) · Nature · doi:10.1038/nature07567 · Cited by 1,796
“Indeed, human leukemias exhibit a modestly higher frequency of leukemogenic cells when assayed in mice that are more highly immunocompromised than NOD/SCID mice15,16, although leukemogenic cells still represent only 1% of cells in one such model17.”
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Shackleton, M., Quintana, E., Fearon, E. R., & Morrison, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.08.017 · Cited by 1,162
“These effects can be mitigated by expressing human growth factors in mice (Lapidot et al., 1994; Feuring-Buske et al., 2003) and by optimizing the site of transplantation (Kennedy et al., 2007).”
BackgroundIshikawa, F., Yoshida, S., Saito, Y., Hijikata, A., Kitamura, H., Tanaka, S., Nakamura, R., Tanaka, T., Tomiyama, H., Saito, N., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1350 · Cited by 909
Metadata
- Authors
- Feuring-Buske, M., Gerhard, B., Cashman, J., Humphries, R. K., Eaves, C. J., & Hogge, D. E.
- Affiliations
- BC Cancer Agency (CA)
- Venue
- Leukemia
- Published
- 2003-04-01
- Volume
- 17
- Issue
- 4
- Pages
- 760-763
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W1999453504
- Cited by
- 116
- References
- 22
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 8 · 2019: 6 · 2018: 7 · 2017: 5 · 2016: 9 · 2015: 6 · 2014: 2 · 2013: 12 · 2012: 7
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Leukemia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Krebshilfe
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- acute myeloid leukemia, leukemia-initiating cells, NOD/SCID mice, transgenic mice, stem cell factor, interleukin-3, GM-CSF, bone marrow engraftment, limiting dilution
- MeSH terms
- Acute Disease, Animals, beta 2-Microglobulin, Bone Marrow, Flow Cytometry, Graft Survival, Humans, Interleukin-3, Leukemia, Myeloid, Mice, Transgenic, Neoplasm Transplantation, Radiation Chimera, Recombinant Fusion Proteins, Transplantation, Heterologous, Granulocyte-Macrophage Colony-Stimulating Factor, Mice, SCID, Mice, Inbred NOD, In Situ Hybridization, Fluorescence, Mice, Knockout, Stem Cell Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.